Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma

Lan-Lan Wang; Chen Liao; Xiao-Qiang Li; Rong Dai; Qing-Wei Ren; Hai-Long Shi; Xiao-Ping Wang; Xue-Song Feng; Xu Chao

doi:10.12659/MSM.927624

13 January 2021 : Database Analysis

Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma

Lan-Lan Wang^1BE, Chen Liao^2C, Xiao-Qiang Li^3C, Rong Dai^2C, Qing-Wei Ren^4B, Hai-Long Shi^1C, Xiao-Ping Wang^1F, Xue-Song Feng^1E, Xu Chao^14AG*

DOI: 10.12659/MSM.927624

Med Sci Monit 2021; 27:e927624

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 1 Exploration of the active chemical components of Tu Bei Mu (TBM) through a ligand-based prediction strategy.

Molecule ID	Molecule name	OB	DL
MOL000357	Sitogluside	20.63	0.62
MOL000358	beta-sitosterol	36.91	0.75
MOL000359	Sitosterol	36.91	0.75
MOL000472	Emodin	24.40	0.24
MOL002440	Cucurbitacin b	25.90	0.75
MOL010314	Daucosterol palmitate	25.51	0.19
MOL010315	beta-sitosterol palmitate	30.90	0.41
MOL010324	7β,20,26-trihydroxy-20(s)-24E-dammaragonene-3-O-α-L-arabinopyranose-(l–2)-β-D-(6′-acetyl)-glucopyranoside_qt	28.89	0.79
MOL010328	7β,20,26-trihydroxy-20(s)-24E-dammaragonene-3-O-α-L-(4′-acetyl)-arabinopyranose-(l–2)-β-D-glucopyranoside_qt	28.14	0.80

Back to the Article

Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma

Your Privacy